Quick Answer
Dermata Therapeutics, Inc. reported Total Assets of $7.86 million for fiscal year 2025.
Dermata Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $7.86M | +122.5% |
| 2024 | $3.53M | -55.7% |
| 2023 | $7.98M | +14.9% |
| 2022 | $6.94M | -40.3% |
| 2021 | $11.62M | +1819.9% |
| 2020 | $605.5K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.07M | -24.2% | -23.6% |
| June 30, 2025 | $6.64M | +26.8% | -33.6% |
| March 31, 2025 | $10.01M | +93.2% | +183.1% |
| December 31, 2024 | $3.53M | -55.7% | -47.2% |
| September 30, 2024 | $6.69M | -8.7% | +27.7% |
| June 30, 2024 | $5.24M | -39.9% | +1.1% |
| March 31, 2024 | $5.18M | -44.3% | -35.1% |
| December 31, 2023 | $7.98M | +14.9% | +8.9% |
- Dermata Therapeutics, Inc. showed an increase of +122.5% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Dermata Therapeutics, Inc.’s total assets has grown by 1198.8% (from $605.5 thousand to $7.86 million).
- The most recent figure is from Dermata Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: